Skip to search formSkip to main contentSkip to account menu

MOPP-ABV hybrid protocol

Known as: MOPP/ABV Hybrid Regimen, Mustargen-Oncovin-Procarbazine-Prednisone plus Adriamycin-Bleomycin-Vinblastine Hybrid Regimen 
A non-cross resistant regimen in which half of the MOPP regimen is administered with half of the ABV regimen and is used for the initial treatment of… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2009
Highly Cited
2009
BackgroundProventricular dilatation disease (PDD) is a fatal disorder of psittacine birds worldwide. The disease is characterized… 
Review
2005
Review
2005
Review
2004
Review
2004
Hodgkin's disease demonstrates an exquisite sensitivity to chemotherapy and radiation therapy. This necessitates investigation of… 
Highly Cited
2003
Highly Cited
2003
BACKGROUND The use of involved-field radiotherapy after chemotherapy for advanced Hodgkin's lymphoma is controversial. METHODS… 
2000
2000
Combination chemotherapy, including hybrid regimens, is the standard treatment for patients with advanced Hodgkin disease (HD… 
1999
1999
Knowledge Discovery in Databases (also known as Data Mining) is a powerful paradigm for automated knowledge acquisition. In this… 
Highly Cited
1998
Highly Cited
1998
PURPOSE To compare the efficacy of sequential mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) followed by… 
Highly Cited
1997
Highly Cited
1997
PURPOSE This randomized, prospective trial compares outcomes for patients with advanced Hodgkin's disease treated with… 
1992
1992
A 43-year-old man presented with simultaneously occurring alopecia areata and stage IIIB nodular sclerosing Hodgkin's disease…